FrancophonIA/ELRC3.0 huggingface dataset:
English: Each patch of 20 cm contains 9.0 mg of rotigotine.
Croatian: Jedan flaster površine 20 cm2 sadrži 9,0 mg rotigotina.
English: Leganto may potentiate the dopaminergic adverse reaction of L-dopa and may cause and/or exacerbate pre-existing dyskinesia, as described with other dopamine agonists.
Croatian: Kao i drugi agonisti dopamina, tako i Leganto može pojačati nuspojave dopaminergičkog tipa koje uzrokuje primjena levodope i može uzrokovati pojavu diskinezije i/ili pogoršati postojeću diskineziju.
English: • Gently wash the area with warm water and mild soap.
Croatian: • Područje nježno operite toplom vodom i blagim sapunom kako biste uklonili sve tragove ljepila na koži.
English: Tell your doctor or pharmacist if you notice any side effects.
Croatian: Recite svom liječniku ili ljekarniku ako primijetite bilo koju nuspojavu.
English: Based on the analysis of pooled placebo-controlled clinical trials comprising a total of 1,307 Legantoand 607 placebo-treated patients, 72.5% of the patients on Leganto and 58.0% of patients on placebo reported at least one adverse reaction.
Croatian: Analizom objedinjenih podataka iz placebom kontroliranih kliničkih ispitivanja u kojima je sudjelovalo ukupno 1307 bolesnika koji su primjenjivali Leganto te 607 bolesnika koji su primali placebo, najmanje jedna nuspojava zabilježena je u 72,5% bolesnika liječenih Legantom i u 58,0% bolesnika na placebu.
English: Application and instillation site reactions a
Croatian: Opći poremećaji i reakcije na mjestu primjene reakcije na mjestu primjenea
English: In trials where the application sites were rotated as reflected in the instructions provided in the SmPC and package leaflet, 34.2% of 748 patients using Leganto, experienced application site reactions.
Croatian: U ispitivanjima u kojima je mjesto primjene mijenjano u skladu s preporukama koje se nalaze u sažetku opisa svojstava lijeka i uputi o lijeku, u 34,2% od 748 bolesnika koji su primjenjivali Leganto zabilježene su reakcije na mjestu primjene.
English: Read the package leaflet before use.
Croatian: NAČIN PRIMJENE LIJEKA Prije uporabe pročitajte uputu o lijeku.
English: erythema, pruritus, irritation, rash, dermatitis, vesicles, pain, eczema, inflammation, swelling, discolouration, papules, exfoliation, urticaria, hypersensitivity)
Croatian: (uključujući eritem, svrbež, iritaciju, osip, dermatitis, vezikule, bol, ekcem, upalu, oteklinu, promjenu boje kože, papule, eksfolijaciju, urtikariju, preosjetljivost)
English: At the end of the maintenance treatment in 92% of the subjects in the rotigotine arm, the optimal dose was the maximal dose allowed i.e. 8 mg/24 h. An improvement of 20% was seen in 52% of the subjects receiving rotigotine, 68% of the subjects receiving ropinirole and 30% of the subjects receiving placebo (Difference rotigotine versus placebo 21.7%, CI95% 11.1%; 32.4%, difference ropinirole versus placebo 38.4%, CI95% 28.1%; 48.6%, difference ropinirole versus rotigotine 16.6%, CI95% 7.6%; 25.7%).
Croatian: Poboljšanje od 20% zabilježeno je u 52% ispitanika koji su primali rotigotin-, u 68% ispitanika koji su primali ropinirol- i u 30% ispitanika koji su primali placebo (razlika rotigotin naprama placebo 21,7%, CI95%: 11,1%; 32,4%, razlika ropinirol naprama placebo 38,4%, CI95%: 28,1%; 48,6%, razlika ropinirol naprama rotigotin 16,6%, CI95%: 7,6%; 25,7%).
English: At the end of the maintenance treatment an improvement of at least 30% was seen in 60% of the subjects receiving rotigotine, 67% of the subjects receiving pramipexole and 35% of the subjects receiving placebo (Difference rotigotine versus placebo 25%, CI95% 13%; 36%, difference pramipexole versus placebo 32%, CI95% 21%; 43%, difference pramipexole versus rotigotine 7%, CI95% -2%; 17%).
Croatian: Na kraju terapije održavanja, poboljšanje od najmanje 30% zabilježeno je u 60% ispitanika koji su primali rotigotin, 67% ispitanika koji su primali pramipeksol i u 35% ispitanika koji su primali placebo (razlika rotigotin naprama placebo 25%, CI95%: 13%; 36%, razlika pramipeksol naprama placebo 32%, CI95%: 21%; 43%, razlika pramipeksol naprama rotigotin 7%, CI95%: -2%; 17%).
English: Ltd Τηλ: +357-22 05 63 00
Croatian: Lifepharma (Z.A.M.) Ltd Τηλ: +357-22 34 74 40
English: Vomiting, dyspepsia
Croatian: • povraćanje, žgaravica
English: The outside is tan-coloured and is imprinted with Leganto 1 mg/24 h or 3 mg/24 h.
Croatian: Vanjska strana je boje kože s otisnutim natpisom Leganto 1 mg/24 h ili 3 mg/24 h.
English: Leganto 2 mg/24 h Leganto 4 mg/24 h Leganto 6 mg/24 h Leganto 8 mg/24 h Transdermal patch
Croatian: Leganto 2 mg/24 h Leganto 4 mg/24 h Leganto 6 mg/24 h Leganto 8 mg/24 h Transdermalni flaster rotigotin
English: • delirium
Croatian: • delirij
English: These occurred in 3.4% of Japanese subjects on rotigotine compared to 1.9% on placebo in double-blind Parkinson's disease and RLS studies.
Croatian: U dvostruko slijepim ispitivanjima Parkinsonove bolesti i sindroma nemirnih nogu one su se pojavile u 3,4% japanskih ispitanika koji su bili na rotigotinu u usporedbi s 1,9% onih na placebu.
English: pathological gambling, stereotypy/ punding, binge eating/eating disorder b, compulsive shopping c)
Croatian: (uključujući patološko kockanje, stereotipne/pona vljajuće besmislene radnje, prejedanje/pore mećaj prehraneb, kompulzivno kupovanjec)
English: • feeling weak (fatigue)
Croatian: • slabost (umor)
English: Psychotic disorder, obsessivecompulsive disorder, aggressive behaviour/ aggression b,
Croatian: opsesivnokompulzivni poremećaj, agitacijad agresivno ponašanje/ agresijab, dezorijentacij sindrom dopaminergi čke disregulacijec
English: Leganto 1 mg/24 h transdermal patch Leganto 3 mg/24 h transdermal patch
Croatian: Leganto 1 mg/24 h transdermalni flaster Leganto 3 mg/24 h transdermalni flaster
English: At the end of the maintenance treatment an improvement of at least 30% was seen in 57% and 55% of the subjects receiving rotigotine 8 mg/24 h and 12 mg/24 h, respectively and in 34% of the subjects receiving placebo (Differences 22% and 21%, respectively, CI95% 10%; 35% and 8%; 33%, respectively, p<0.001 for both rotigotine groups).
Croatian: Na kraju terapije održavanja, poboljšanje od najmanje 30% zabilježeno je u 57%, odnosno 55% ispitanika koji su primali rotigotin 8 mg/24 h, odnosno 12 mg/24 h te u 34% ispitanika koji su primali placebo (razlike 22%, odnosno 21%, CI95%: 10%; 35%, odnosno 8%; 33%; p<0,001 za obje rotigotin-skupine).
English: Adverse drug reactions (ADRs) reported in more than 10% of patients treated with Leganto are nausea, application site reactions, asthenic conditions and headache.
Croatian: Nuspojave zabilježene u više od 10% bolesnika liječenih Legantom jesu mučnina, reakcija na mjestu primjene, astenična stanja i glavobolja.
English: Adjustment of the dose is not necessary in patients with mild to moderate hepatic impairment.
Croatian: U bolesnika s blagim do umjerenim oštećenjem jetre ne treba prilagođavati dozu.
English: How to use the patch
Croatian: Kako primjenjivati flaster
English: • vomiting, heartburn
Croatian: • pospanost, omaglica
English: Reproductive system and breast disorder
Croatian: Poremećaj reproduktivnog sustava i dojki erektilna disfunkcijae
English: Each patch of 10 cm contains 4.5 mg of rotigotine.
Croatian: Jedan flaster površine 10 cm2 sadrži 4,5 mg rotigotina.
English: The outside of the backing layer is tan-coloured and imprinted with ‘Leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h or 8 mg/24 h'.
Croatian: Vanjski potporni sloj jest boje kože s otisnutim „Leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h ili 8 mg/24 h“.
English: Leganto 8 mg/24 h transdermal patch The outside of the backing layer is tan-coloured and imprinted with ‘Leganto 8 mg/24 h'.
Croatian: Leganto 8 mg/24h transdermalni flaster Vanjski potporni sloj jest boje kože s otisnutim „Leganto 8 mg/24 h“.
English: The patients were titrated to their optimal dose of rotigotine or placebo in weekly increments of 2 mg/24 h starting at 2 mg/24 h to a maximum dose of 16 mg/24 h over 8 weeks, followed by a maintenance period of 4 weeks.
Croatian: Bolesnici su titrirani do njihove optimalne doze rotigotina ili placeba u tjednim intervalima s povećanjima za 2 mg/24 h, počevši od 2 mg/24 h do najveće doze od 16 mg/24 h kroz 8 tjedana, nakon čega je slijedio period održavanja u trajanu od 4 tjedna.
English: Patients in each treatment group were maintained for 4 months.
Croatian: Bolesnici u svim terapijskim skupinama zatim su 4 mjeseca primjenjivali optimalnu dozu.
English: Respiratory, thoracic and mediastinal disorders
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja štucanjee
English: Vascular disorders
Croatian: Dopaminergičke nuspojave
English: AST, ALT, GGT), weight increased, heart rate increased, CPK increased d
Croatian: (uključujući AST, ALT, GGT), povećanje tjelesne težinee, ubrzanje srčane frekvencijee, povišena kreatin fosfokinaza (CPK)d,e
English: In clinical trial studies with rotigotine, syncope has been observed at a rate that was similar to that observed in patients treated with placebo.
Croatian: U kliničkim ispitivanjima rotigotinom, primjećena je sinkopa sa stopom sličnom onoj primjećenoj u bolesnika koji su primali placebo.
English: The outside of the backing layer is tan-coloured and imprinted with ‘Leganto 2 mg/24 h'.
Croatian: Vanjski potporni sloj jest boje kože s otisnutim „Leganto 2 mg/24 h“.
English: Leganto may decrease blood pressure when you stand up
Croatian: Leganto može sniziti krvni tlak pri ustajanju; taj učinak mogu pogoršati lijekovi za snižavanje krvnog tlaka.
English: The patients were titrated to their optimal dose of rotigotine in weekly increments of 2 mg/24 h starting at 4 mg/24 h to a maximum dose of 16 mg/24 h. In the pramipexole group, patients received 0,375 mg in the first week, 0.75 mg in the second week and were titrated further in weekly increments of 0.75 mg to their optimal dose up to a maximum of 4.5 mg/day.
Croatian: U pramipeksol-skupini bolesnici su prvi tjedan primali 0,375 mg, drugi tjedan 0,75 mg, a zatim su titrirani u tjednim razmacima za 0,75 mg do optimalne doze, odnosno do najveće doze od 4,5 mg/dan.
English: • 8 mg/24 h: Each patch releases 8 mg of rotigotine per 24 hours.
Croatian: • 8 mg/24 h: Jedan flaster oslobađa 8 mg rotigotina u 24 sata.
English: Nausea, vomiting Constipation, dry mouth, dyspepsia
Croatian: Poremećaji probavnog sustava mučnina, povraćanje konstipacija , suha usta, dispepsija bol u abdoemnu proljevc
English: • The maximum dose is 8 mg each day.
Croatian: • Najveća doza je 8 mg na dan.
English: Early morning motor function, assessed by UPDRS part III, and nocturnal sleep disturbances, measured by the modified Parkinson's Disease Sleep Scale (PDSS-2), were co-primary outcome measures.
Croatian: Mjere primarnog ishoda bile su: ranojutarnje motoričke funkcije koje su ocijenjivane prema UPDRS ljestvici (dijelom III) te noćne smetnje spavanja koje su ocijenjivane modificiranom ljestvicom za ocjenu kvalitete spavanja u bolesnika s Parkinsonovom bolešću (eng.
English: erythema, pruritus, irritation, rash, dermatitis, vesicles, pain, eczema, inflammation, swelling, discolouration, papules, exfoliation, urticaria, hypersensitivity), asthenic conditions a
Croatian: (uključujući eritem, svrbež, iritaciju, osip, dermatitis, vezikule, bol, ekcem, upalu, oteklinu, promjenu boje kože, papule, eksfolijaciju, urtikariju, preosjetljivost), astenična stanjaa
English: syncope, syncope vasovagal, loss of consciousness), dyskinesia, dizziness postural, lethargy
Croatian: (uključujući sinkopu, vazovagalnu sinkopu, gubitak svijesti), diskinezijae, posturalna omaglicae, letargijae, konvulzijae
English: 7 transdermal patches of Leganto 4 mg/24 h
Croatian: 7 transdermalnih flastera Leganta 4 mg/24 h
English: • To help avoid the skin reactions, you should put the patch on a different area of skin every day,
Croatian: • Kako biste izbjegli kožne reakcije, flaster svaki dan stavite na drugo područje kože i nemojte ga staviti dvaput na isto mjesto unutar 14 dana.
English: • Peel off one side of the release liner.
Croatian: • Odlijepite jednu stranu zaštitnog sloja.
English: Heat application
Croatian: Izlaganje vrućini
English: BOX OF 7 PATCHES - WEEK 1
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA SA 7 FLASTERA - TJEDAN 1
English: • vertigo (sensation of whirling motion)
Croatian: • vrtoglavica (osjećaj okretanja)
English: Leganto can cause side effects that change your behaviour (how you act).
Croatian: Leganto može uzrokovati i druge promjene u ponašanju i razmišljanju, koji mogu uključivati:
English: 7 transdermal patches of Leganto 8 mg/24 h
Croatian: 7 transdermalnih flastera Leganta 8 mg/24 h
English: You may have to use more than one patch to reach your dose, as prescribed by your doctor.
Croatian: morate primijeniti više flastera kako biste postigli konačnu dozu.
English: A single daily dose should be initiated at 4 mg/24 h and then increased in weekly increments of 2 mg/24 h to an effective dose up to a maximum dose of 16 mg/24 h.
Croatian: Liječenje treba započeti jednokratnom dnevnom dozom od 4 mg/24 h, a zatim je povećavati za 2 mg/24 h u tjednim razmacima do učinkovite doze, maksimalno do doze od 16 mg/24 h.
English: Talk to your doctor or pharmacist if you notice any of the side effects listed above.
Croatian: Obratite se svom liječniku ili ljekarniku ako primijetite bilo koju od navedenih nuspojava.
English: 7 transdermal patches of Leganto 6 mg/24 h
Croatian: 7 transdermalnih flastera Leganta 6 mg/24 h
English: Discontinuation rate
Croatian: Način primjene
English: See leaflet for further information.
Croatian: Za ostale informacije pročitajte uputu o lijeku.
English: • abnormal heart beat
Croatian: • ubrzani otkucaji srca
English: 7 transdermal patches.
Croatian: OBLIK I SADRŽAJ 7 transdermalnih flastera.
English: Each patch releases 8 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 8 mg rotigotina u 24 sata.
English: • Belly.
Croatian: • trbuh
English: Backing layer
Croatian: Potporni sloj
English: • Press the sticky side of the patch firmly into place.
Croatian: • Pritisnite i pričvrstite ljepljivu stranu na kožu.
English: Marketing Authorisation Holder
Croatian: Nositelj odobrenja za stavljanje u promet lijeka
English: The outside is tan-coloured and is imprinted with Leganto 4 mg/24 h Leganto 6 mg/24 h or Leganto 8 mg/24 h.
Croatian: Vanjska strana je boje kože s otisnutim natpisom Leganto 4 mg/24 h, Leganto 6 mg/24 h ili Leganto 8 mg/24 h.
English: • stomach discomfort and pain
Croatian: • nelagoda i bol u želucu
English: Each patch releases 6 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 6 mg rotigotina u 24 sata.
English: Leganto 4 mg/24 h transdermal patch The outside of the backing layer is tan-coloured and imprinted with ‘Leganto 4 mg/24 h'.
Croatian: Leganto 4 mg/24 h transdermalni flaster Vanjski potporni sloj jest boje kože s otisnutim „Leganto 4 mg/24 h“.
English: The outside is tan-coloured and is imprinted with Leganto 2 mg/24 h.
Croatian: Vanjska strana je boje kože s otisnutim natpisom Leganto 2 mg/24 h.
English: BOX OF 7 PATCHES - WEEK 4
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA SA 7 FLASTERA - TJEDAN 4
English: Leganto 6 mg/24 h transdermal patch The outside of the backing layer is tan-coloured and imprinted with ‘Leganto 6 mg/24 h'.
Croatian: Leganto 6 mg/24h transdermalni flaster Vanjski potporni sloj jest boje kože s otisnutim „Leganto 6 mg/24 h“.
English: • 6 mg/24 h: Each patch releases 6 mg of rotigotine per 24 hours.
Croatian: • 6 mg/24 h: Jedan flaster oslobađa 6 mg rotigotina u 24 sata.
English: Leganto 8 mg/24 h transdermal patch EU/1/11/695/046
Croatian: Leganto 8 mg/24 h transdermalni flaster EU/1/11/695/046
English: Leganto is available in different strength patches which release the medicine over 24 hours.The strengths are 1 mg/24 h, 2 mg/24 h and 3 mg/24 h for the treatment of Restless Leg Syndrome.
Croatian: Jačine su: 1 mg/24 h, 2 mg/24 h i 3 mg/24 h za liječenje sindroma nemirnih nogu.
English: BOX OF 7 PATCHES - WEEK 2
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA SA 7 FLASTERA - TJEDAN 2
English: The strengths are 1 mg/24 h, 2 mg/24 h, 3 mg/24 h, 4 mg/24 h, 6 mg/24 h and 8 mg/24 h. The patches of 1 mg/24 h and 3 mg/24 h are used for the treatment of Restless Leg Syndrome, while the patches of 4 mg/24 h, 6 mg/24 h and 8 mg/24 h are used for the treatment of Parkinson's disease.
Croatian: Flasteri od 1 mg/24 h i 3 mg/24 h mogu se upotrebljavati za liječenje sindroma nemirnih nogu, a flasteri od 4 mg/24 h, 6 mg/24 h i 8 mg/24 h mogu se upotrebljavati za liječenje Parkinsonove bolesti.
English: A single daily dose should be initiated at 2 mg/24 h and then increased in weekly increments of 2 mg/24 h to an effective dose up to a maximum dose of 8 mg/24 h.
Croatian: Liječenje treba započeti jednokratnom dnevnom dozom od 2 mg/24 h, a zatim je povećavati za 2 mg/24 h u tjednim razmacima do učinkovite doze, maksimalno do doze od 8 mg/24 h.
English: Leganto 4 mg/24 h transdermal patch Leganto 6 mg/24 h transdermal patch Leganto 8 mg/24 h transdermal patch
Croatian: Leganto 4 mg/24 h transdermalni flaster Leganto 6 mg/24 h transdermalni flaster Leganto 8 mg/24 h transdermalni flaster
English: The signs include: loss of muscle movement (akinesia), rigid muscles, fever, unstable blood pressure, increased heart rate (tachycardia), confusion, low level of consciousness (such as a coma).
Croatian: Znakovi uključuju: gubitak mišićnih pokreta (akinezija), ukočenost mišića, vrućicu, nestabilan krvni tlak, ubrzane otkucaje srca (tahikardija), smetenost, smanjenu razinu svijesti (poput kome).
English: Each patch releases 1 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 1 mg rotigotina u 24 sata.
English: BOX OF 7 PATCHES - WEEK 3
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA SA 7 FLASTERA - TJEDAN 3
English: • For most patients, the right dose is between 6 mg and 8 mg each day.
Croatian: • Odgovarajuća doza za većinu bolesnika je između 6 mg i 8 mg na dan, koja se obično postiže unutar 3 - 4 tjedna
English: The outside is tan-coloured and is imprinted with Leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h or 8 mg/24 h.
Croatian: Vanjska strana je boje kože s otisnutim natpisom Leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h ili 8 mg/24 h.
English: The patients were titrated to their optimal dose of rotigotine in weekly increments of 2 mg/24 h starting at 2 mg/24 h to a maximum dose of 8 mg/24 h over 4 weeks.
Croatian: Optimalna doza rotigotina postignuta je titracijom doze u tjednim razmacima za 2 mg/24 h, počevši od 2 mg/24 h do najveće doze od 8 mg/ 24 h kroz 4 tjedna.
English: • your eyes need checking regularly while using Leganto.
Croatian: • tijekom liječenja Legantom potrebne su redovite kontrole vida.
English: Tel.: +48-22 696 99 20
Croatian: UCB Pharma Sp. z o.o. Tel.: +48-22 696 99 20
English: EU/1/11/695/046 [7 transdermal patches] EU/1/11/695/048 [28 transdermal patches] EU/1/11/695/049 [30 transdermal patches]
Croatian: EU/1/11/695/046 [7 transdermalnih flastera] EU/1/11/695/048 [28 transdermalnih flastera] EU/1/11/695/049 [30 transdermalnih flastera]
English: Leganto 1 mg/24 h transdermal patch EU/1/11/695/001
Croatian: Leganto 1 mg/24 h transdermalni flaster EU/1/11/695/001
English: leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h, 8 mg/24 h
Croatian: 16. PODACI NA BRAILLEOVOM PISMU leganto 2 mg/24 h, 4 mg/24 h, 6 mg/24 h, 8 mg/24 h
English: At the end of the maintenance treatment in 91% of the subjects in the rotigotine arm, the optimal dose was the maximal dose allowed i.e. 6 mg/24 h. An improvement of 20% was seen in 48% of the subjects receiving rotigotine and in 19% of the subjects receiving placebo (Difference 29%, CI95% 18%; 39%, p<0.0001).
Croatian: Poboljšanje od 20% zabilježeno je u 48% ispitanika liječenih rotigotinom i u 19% ispitanika koji su primali placebo (razlika 29%, CI95%: 18%; 39%, p < 0,0001).
English: Sleep attacks/sudden onset of sleep, sexual desire disorders a
Croatian: Psihijatrijski poremećaji napadi spavanja/iznena dne epizode spavanja, poremećaji spolne željea
English: • 3 mg/24 h: Each patch releases 3 mg of rotigotine per 24 hours.
Croatian: • 3 mg/24 h: Jedan flaster oslobađa 3 mg rotigotina u 24 sata.
English: EU/1/11/695/001 [7 transdermal patches] EU/1/11/695/003 [28 transdermal patches] EU/1/11/695/004 [30 transdermal patches]
Croatian: EU/1/11/695/001 [7 transdermalnih flastera] EU/1/11/695/003 [28 transdermalnih flastera] EU/1/11/695/004 [30 transdermalnih flastera]
English: Tell your doctor, pharmacist or nurse if you notice any of the side effects listed above.
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri ako primijetite bilo koju od navedenih nuspojava.
English: • For most patients, the right dose is between 8 mg and 16 mg each day.
Croatian: • Odgovarajuća doza za većinu bolesnika je između 8 mg i 16 mg na dan, koja se obično postiže unutar 3 - 7 tjedana
English: • Each patch releases 2 mg of rotigotine per 24 hours.
Croatian: • Jedan flaster oslobađa 2 mg rotigotina u 24 sata.
English: EU/1/11/695/028 [7 transdermal patches] EU/1/11/695/030 [28 transdermal patches] EU/1/11/695/031 [30 transdermal patches]
Croatian: EU/1/11/695/028 [7 transdermalnih flastera] EU/1/11/695/030 [28 transdermalnih flastera] EU/1/11/695/031 [30 transdermalnih flastera]
English: • Your starting dose will be one 1 mg/24 h patch each day.
Croatian: • Početna doza bit će jedan flaster od 1 mg/24 h na dan.
English: • 4 mg/24 h: Each patch releases 4 mg of rotigotine per 24 hours.
Croatian: • 4 mg/24 h: Jedan flaster oslobađa 4 mg rotigotina u 24 sata.
English: • Your starting daily dose will be one 4 mg/24 h patch each day.
Croatian: • Početna doza bit će jedan flaster od 4 mg/24 h na dan.
English: Leganto 3 mg/24 h transdermal patch
Croatian: Leganto 3 mg/24 h transdermalni flaster
English: Leganto 8 mg/24 h transdermal patch rotigotine
Croatian: Leganto 8 mg/24 h transdermalni flaster rotigotin
English: For example the daily dose of 10 mg may be reached by applying one patch of 6 mg/24 h and one patch of 4 mg/24 h.
Croatian: mg moguće je postići primjenom jednog flastera od 6 mg/24 h i jednog flastera od 4 mg/24 h.
English: Leganto 6 mg/24 h transdermal patch EU/1/11/695/037
Croatian: Leganto 6 mg/24 h transdermalni flaster EU/1/11/695/037
English: Leganto 3 mg/24 h transdermal patch EU/1/11/695/019
Croatian: Leganto 3 mg/24 h transdermalni flaster EU/1/11/695/019
English: • blurry vision
Croatian: • zamagljen vid
English: Dopamine dysregulation syndromec, perception disturbances e
Croatian: Psihijatrijski poremećaji poremećaji percepcijea
English: Rotigotine
Croatian: • svrbež
English: Each patch releases 3 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 3 mg rotigotina u 24 sata.
English: Transdermal use
Croatian: Transdermalni flaster
English: Each patch releases 4 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 4 mg rotigotina u 24 sata.
English: Leganto 4 mg/24 h transdermal patch EU/1/11/695/028
Croatian: Leganto 4 mg/24 h transdermalni flaster EU/1/11/695/028
English: Leganto 1 mg/24 h transdermal patch rotigotine
Croatian: Leganto 1 mg/24 h transdermalni flaster rotigotin
English: Tell your doctor if you lose consciousness or feel dizzy.
Croatian: Ako izgubite svijest ili osjećate omaglicu, obratite se svom liječniku.
English: A single daily dose should be initiated at 1 mg/24 h. Depending on the individual patient response, the dose may be increased in weekly increments of 1 mg/24 h to a maximum dose of 3 mg/24 h. The need for treatment continuation should be reconsidered every 6 months.
Croatian: Ovisno o odgovoru svakog pojedinog bolesnika doza se može povećavati u tjednim intervalima za 1 mg/24 h do najveće doze 3 mg/24 h.
English: Nervous system disorders
Croatian: Poremećaj reproduktivnog sustava dojki erektilna disfunkcijae
English: Each patch releases 2 mg of rotigotine per 24 hours.
Croatian: Jedan flaster oslobađa 2 mg rotigotina u 24 sata.
English: • Your starting daily dose will be one 2 mg/24 h patch each day.
Croatian: • Početna doza bit će jedan flaster od 2 mg/24 h na dan.
English: 4 mg/24 h or 6 mg/24 h may be effective doses in some patients.
Croatian: Za neke bolesnike učinkovita doza može biti 4 mg/24 h, odnosno 6 mg/24 h.